Vericel Corp. (VCEL)
31.41
-1.33
(-4.06%)
USD |
NASDAQ |
Mar 20, 16:00
31.46
+0.05
(+0.16%)
After-Hours: 20:00
Vericel Total Liabilities (Quarterly) : 133.33M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 20.31M |
| Moderna, Inc. | 3.688B |
| Marker Therapeutics, Inc. | 2.274M |
| X4 Pharmaceuticals, Inc. | 104.17M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 487.97M |
| Shareholders Equity (Quarterly) | 354.64M |
| Debt to Equity Ratio | 0.2771 |
| Current Ratio | 5.034 |
| Net Debt Paydown Yield | -0.01% |